P039-1841 Screening compound: N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

P039-1841 Screening compound: N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide
P039-1841 Screening compound: N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P039-1841
N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P039-1841

Molecular Formula

C20H17FN6O3 (C20 H17 FN6 O3)

Compound Name

N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-1,4,5,6-tetrahydropyridazin-1-yl}acetamide

IUPAC name

N-(2-fluoro-4-methylphenyl)-2-{6-oxo-3-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]-1456-tetrahydropyridazin-1-yl}acetamide

SMILES

Cc(cc1)cc(F)c1NC(CN(C(CC1)=O)N=C1c1nc(-c2ccncc2)no1)=O

InChI

InChI=1S/C20H17FN6O3/c1-12-2-3-15(14(21)10-12)23-17(28)11-27-18(29)5-4-16(25-27)20-24-19(26-30-20)13-6-8-22-9-7-13/h2-3,6-10H,4-5,11H2,1H3,(H,23,28)

InChI Key

LVHQMXIKMYDLNH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27559855

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

408.39

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.167

Distribution Coefficient, logD

2.167

Water Solubility, LogSw

-2.61

Polar Surface Area

92.105

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

P039-1841 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P039-1841 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P039-1841?
Check Price and Availability of P039-1841, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P039-1841 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P039-1841
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P039-1841
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P039-1841 available by request